Interstitial Cystitis - Few Treatments, Poor Outcome - Market Research Reports - Research and Markets

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/336028

Interstitial Cystitis - Few Treatments, Poor Outcome

Description:

Interstitial cystitis (IC) is considered a rare disorder and poor understanding of the underlying causes of the disorder have made diagnosis and management difficult. Moreover, this has impacted on the development of effective drugs for this disorderthere are few available treatments for IC and as a result, significant unmet needs exist.

Scope of this title:
- Quantitative treatment data from 190 physicians based in US, Japan, France, Germany, Italy, Spain and UK; supported by key opinion leader comments
- Analysis of epidemiology, presentation and referral patterns, diagnostic assessment, and first- to second-line treatments for IC
- Influences on treatment choice and perception of current drug therapies including pentosan polysulfate sodium and the antimuscarinics
- Influences on treatment choice and perception of current drug therapies, unmet needs and future outlook including the R&D drug pipeline

Highlights of this title:
Presentation rates for IC are higher than in other OAB disorders due to the patient experience of pain. However, discord in the terminology and diagnostic criteria for IC confound diagnosis; and as result, the diagnosis of IC tends to be one of exclusion, and as such can take many years to be reached, bringing unnecessary suffering to the patient.

IC symptoms have a similar terminology to those of Overactive Bladder, but are fundamentally different. Poor understanding of the disorder and limited treatment options means that many physicians have resorted to using antimuscarinics despite their limited proven efficacy in treating the pain.

Further research into the etiology of IC is the key to finding a truly effective treatment for IC that works. In the meantime, companies wishing to target the IC market should aim to demonstrate the ability of their drug to treat pain in addition to urgency and frequency.

Reasons to order your copy:
- Forecast product sales by understanding key aspects of IC epidemiology, diagnosis and treatment
- Gain a better understanding of the challenges facing current and future players in the IC market
- Identify physicians’ key concerns in IC including unmet needs and the attributes that physicians believe are desirable for future treatments

Contents:

OVERVIEW
This product has been designed for delivery in a slide pack format (PowerPoint). 6
Please select the slide pack option from the download menu at the side of the page 6
Introduction 6
Scope of this report 6
Research and analysis highlights 7
Key reasons to read this report 7

APPENDIX A
Research methodology 8
Physician Sample breakdown 8
Urinary Incontinence and Overactive Bladder Insight Study – Physician Questionnaire 9
Section One Overview of Urinary Incontinence and overactive Bladder 9
Epidemiology 9
Presentation 10
Diagnosis 11
Referral pattern 11
Section Two Stress Urinary Incontinence 14
Diagnosis and treatment of SUI 14
Non-pharmacological treatment 15
Pharmacological treatment for SUI 16
Section Three Overactive Bladder With Urge Symptoms and/or Incontinence 19
Diagnosis and treatment of UUI 19
Pharmacological treatment for UUI 20
Diagnosis and treatment of ‘dry OAB’ 23
Pharmacological treatment for dry OAB 24
Section Four Mixed Stress/Urge Urinary Incontinence 27
Diagnosis and treatment of mixed SUI/UUI 27
Non-pharmacological treatment 29
Pharmacological treatment for mixed SUI/UUI 30
Section Five Interstitial Cystitis 33
Diagnosis and treatment of IC 33
Pharmacological treatment for IC 33
Section Six Drug Profiles 37
Section A: Drug influences on physicians’ choice 37
Section B: The general treatment of urinary incontinence and overactive bladder 44
Contributing experts 46
US 46
Japan 46
Europe 47

APPENDIX B

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/336028

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 23/11/2009 08:37:48

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.


Product Name:
Interstitial Cystitis - Few Treatments, Poor Outcome
Web Address:
http://www.researchandmarkets.com/reports/336028
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic (PDF) - Single User		€5,107.00
	Electronic - Enterprisewide		€12,767.00

Contact information
Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed 23/11/2009 08:37:48

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder's Name:

Cardholder's Signature:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)